Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Showcase


Channel Catalog


Channel Description:

Visit One News Page for Italy news from around the world, aggregated from leading sources including newswires, newspapers and broadcast media. Search millions of archived news headlines. This feed provides the Italy news headlines.

older | 1 | .... | 1079 | 1080 | (Page 1081) | 1082 | 1083 | .... | 1102 | newer

    0 0

    Dublin, Dec. 18, 2018 (GLOBE NEWSWIRE) -- The "Heat Stress Monitor Market by Product Type, Application, Offering, Life Form, WBGT Technology, Sensor Type, and Region - Global Forecast to 2023" report has been added to *ResearchAndMarkets.com's* offering.

    *"The heat stress monitor market estimated to grow at a CAGR of 7.07% between 2018 and 2023"*The overall heat stress monitor market is estimated at USD 43.3 million in 2018 and is expected to reach USD 60.9 million by 2023, at a CAGR of 7.07% between 2018 and 2023.

    The market growth is attributed to the growing adoption of heat stress monitoring in athletics and military applications, and growing concerns of environmental and safety regulations for heat stress management. Latent markets in APAC, Africa and the Middle East regions, relatively low cost of heat stress monitors, and integration of artificial intelligence (AI) into heat stress monitors are driving the growth of the heat stress monitor market.

    On the other hand, lack of strict enforcement across industries in emerging economies and lack of awareness and necessary training to deal with heat stress conditions are creating challenges for this market.

    *"Athletics and sports applications are expected to grow at the highest rate during the forecast period"*

    Heat stress monitors are used in athletics training activities to identify heat levels inside the training room and on field and to monitor personal body conditions to avoid heat-related illnesses. Athletic training and sports activities can cause exertional heat-related illness (EHRI). EHRI comprises several states that afflict physically active persons while exercising during heat stress. Thus, growing focus on athletes' health and safety during training is driving the heat stress monitor market for athletics and sports applications.

    *"Heat stress monitor market in the Americas is expected to hold the largest market size during the forecast period"*

    The Americas is among the important markets for heat stress monitors. Safety standards developed by the National Institute for Occupational Safety and Health (NIOSH) and Occupational Safety & Health Administration (OSHA) Group have forced various industries to use heat stress monitors at their workplace. Also, health monitoring in military, athletics, and sports applications contributes to the heat stress monitor market in this region.Companies that can provide an AI integrated heat stress monitor system is expected to emerge as game changers as such system will reduce human intervention and boost the overall efficiency of the production.

    Major companies covered in the heat stress monitor report are TSI (US), Nielsen-Kellerman (US), REED Instruments (US), FLIR Systems/Extech) (US), Romteck (Australia), Sper Scientific (US), Runrite Electronics (South Africa), BESANTEK (Canada), SCADACore (Canada), PCE Instruments) (Germany) LSI LASTEM (Italy), Sato Keiryoki (Japan), Scarlet Tech (Taiwan), Numag Data Systems (India), General tools & Instruments (US) and TES Electrical Electronic (Taiwan).*Key Topics Covered**1 Introduction*
    1.1 Objectives of Study
    1.2 Definition
    1.3 Scope of Study
    1.3.1 Markets Covered
    1.3.2 Geographic Scope
    1.3.3 Years Considered for Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

    *2 Research Methodology*
    2.1 Research Data
    2.1.1 Secondary Data
    2.1.1.1 Key Secondary Sources
    2.1.1.2 Few Important Secondary Sources
    2.1.2 Primary Data
    2.1.2.1 Primary Interviews With Experts
    2.1.2.2 Breakdown of Primaries
    2.1.2.3 Key Data From Primary Sources
    2.1.3 Secondary and Primary Research
    2.1.3.1 Key Industry Insights
    2.2 Market Size Estimation
    2.2.1 Bottom-Up Approach
    2.2.1.1 Approach for Capturing Market Size By Bottom-Up Analysis (Demand Side)
    2.2.2 Top-Down Approach
    2.2.2.1 Approach for Capturing Market Size By Top-Down Analysis (Supply Side)
    2.3 Market Breakdown & Data Triangulation
    2.4 Assumptions

    *3 Executive Summary *

    *4 Premium Insights*
    4.1 Heat Stress Monitor (Hardware/Software and Services) Market, 2015-2023 (USD Million)
    4.2 Heat Stress Monitor Market, By Offering
    4.3 Heat Stress Monitor Market in APAC, By Application and Country (2017)
    4.4 Heat Stress Monitor Market (Hardware/Software and Services), By Region
    4.5 Heat Stress Monitor Market, By Product (2018-2023)

    *5 Market Overview*
    5.1 Introduction
    5.2 Market Dynamics
    5.2.1 Drivers
    5.2.1.1 Growing Adoption of Heat Stress Monitoring in Athletics and Military Applications
    5.2.1.2 Environmental and Safety Regulations for Heat Stress Management
    5.2.1.3 Increasing Awareness About Employees' Safety From Excessive Heat at Workplaces
    5.2.1.4 Increasing Demand for Heat Stress Monitoring in Manufacturing and Mining Industries
    5.2.2 Restraints
    5.2.2.1 Lack of Strict Enforcement Across Industries in Emerging Economies
    5.2.3 Opportunities
    5.2.3.1 Latent Markets in APAC, Africa and Middle East
    5.2.3.2 Integration of AI in Heat Stress Monitor
    5.2.3.3 Low Cost of Heat Stress Monitors Creates More Opportunities
    5.2.4 Challenges
    5.2.4.1 Lack of Awareness/Necessary Training to Deal With Heat Stress Conditions
    5.2.4.2 Lack of Trained Professionals for Heat Stress Monitoring

    *6 Industry Trends*
    6.1 Key Trends
    6.2 Value Chain Analysis
    6.3 Noticeable Government Regulations Pertaining to Heat Stress and Employee Safety

    *7 Heat Stress Monitor Market, By Wet Bulb Globe Temperature (WBGT) Technology*
    7.1 Introduction
    7.2 Wet Bulb
    7.3 Without Wet Bulb

    *8 Heat Stress Monitor Market, By Product Type*
    8.1 Introduction
    8.2 Handheld Heat Stress Monitor
    8.3 Fix/Portable Heat Stress Monitor

    *9 Heat Stress Monitor Market, By Offering*
    9.1 Introduction
    9.2 Hardware & Software
    9.3 Services

    *10 Heat Stress Monitor Market, By Life-Form*
    10.1 Introduction
    10.2 Humans
    10.3 Animals (Cattle)

    *11 Heat Stress Monitor Market, By Sensor Type*
    11.1 Introduction
    11.2 Black Globe/Globe Thermometer
    11.3 Natural Wet Bulb
    11.4 Dry Bulb Thermometer
    11.5 Relative Humidity and Air Flow

    *12 Heat Stress Monitor Market, By Application*
    12.1 Introduction
    12.2 Athletics and Sports
    12.3 Mining and Oil & Gas
    12.4 Military
    12.5 Manufacturing Plants
    12.6 Others

    *13 Geographic Analysis*
    13.1 Introduction
    13.2 Americas
    13.2.1 North America
    13.2.1.1 US
    13.2.1.2 Rest of North America
    13.2.1.2.1 Canada
    13.2.1.2.2 Mexico
    13.2.2 South America
    13.3 Europe
    13.3.1 UK
    13.3.2 Western Europe
    13.3.3 Italy
    13.3.4 Rest of Europe
    13.4 APAC
    13.4.1 Japan
    13.4.2 China & Singapore
    13.4.3 Australia
    13.4.4 Rest of APAC
    13.5 RoW
    13.5.1 Middle East
    13.5.2 Africa

    *14 Competitive Landscape*
    14.1 Overview
    14.2 Key Players in Heat Stress Monitor Market (2017)
    14.3 Competitive Scenario
    14.3.1 Product Developments
    14.3.2 Acquisitions
    14.3.3 Partnerships

    *15 Company Profiles*
    (Business Overview, Products & Solutions Offered, Recent Developments, and SWOT Analysis)*
    15.1 Key Players
    15.1.1 TSI
    15.1.2 Flir Systems (Extech)
    15.1.3 Nielsen-Kellerman
    15.1.4 Reed Instrument
    15.1.5 Romteck Australia
    15.1.6 TES Electrical Electronic
    15.1.7 PCE Instruments
    15.1.8 Sato Keiryoki Mfg.
    15.1.9 LSI Lastem
    15.1.10 Runrite Electronics
    15.2 Other Important Players
    15.2.1 Sper Scientific
    15.2.2 Numag Data Systems
    15.2.3 General Tools & Instruments
    15.3 Key Startup Ecosystem
    15.3.1 Scarlet Tech
    15.3.2 Besantek
    15.3.3 Scadacore
    15.4 Distributors
    15.4.1 Air-Met Scientific
    15.4.2 Envirocon Instrumentation
    15.4.3 Sensidyne
    15.4.4 Doculam
    15.4.5 Anaum International Electronics
    *Details on Business Overview, Products & Solutions Offered, Recent Developments, and SWOT Analysis Might Not Be Captured in Case of Unlisted Companies.For more information about this report visit https://www.researchandmarkets.com/research/gc3rxz/the_60_million?w=12

    Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

    CONTACT:
    CONTACT: ResearchAndMarkets.com
    Laura Wood, Senior Press Manager
    press@researchandmarkets.com
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Temperature and Heat Sensors Reported by GlobeNewswire 42 minutes ago.

    0 0

    VANCOUVER, British Columbia, Dec. 18, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB  OTCQB: RVVQF  Frankfurt: 1IT) and Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland”) are pleased to announce that they have entered into a supply agreement whereby Wayland will purchase up to 8,000 kg of dried flower cannabis from RavenQuest in 2019.  The total quantity will be shipped periodically throughout 2019 as product becomes available.As part of the supply agreement, Wayland will immediately make a one-time payment of $2 million to RavenQuest in anticipation of the first major shipment of cannabis flower in March 2019.  Pricing for the transaction is comparable with prevailing wholesale cannabis prices.

    “RavenQuest is very excited to be working with Wayland as we both do our part to meet the huge demand for cannabis across Canada,” stated George Robinson, CEO of RavenQuest.  “Negotiations were smooth and without major challenges; Ben Ward and his team at Wayland are a pleasure to work with. This supply agreement is a significant win for both sides of the transaction. For RavenQuest’s part, 8,000 kg represents about 80% of our estimated production for 2019, meaning this transaction provides us much more certainty when it comes to selling our 2019 production at competitive prices,” Robinson continued.

    “We are thrilled to be working with George and his team at RavenQuest to provide their specialty indoor product to recreational cannabis consumers across Canada through our existing distribution network. This agreement provides for efficiencies for both companies, constructively working together to meet Canadian demand through our existing resources. At the same time, this allows us to channel our existing supply to the European market,” stated Ben Ward, CEO of Wayland.

    Maricann Group Inc., through its subsidiaries, is operating under the Wayland Group name. For further details see the press release dated September 24, 2018.

    *About RavenQuest BioMed Inc.*

    RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development. RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta. RavenQuest maintains a research partnership with Montreal’s McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant. The Company focuses on partnerships with Indigenous communities.

    *About Wayland Group*

    Wayland is a vertically integrated cultivator and processor of cannabis. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a cannabis cultivation, extraction, formulation, and distribution business under federal licenses from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany, Regensdorf, Switzerland, Allesandria, Piedmont, Italy, Ibague, Colombia, London, UK and now Argentina. Wayland will continue to pursue new opportunities globally in its effort to enhance lives through cannabis.

    On Behalf of the Board of Directors of 
    *RAVENQUEST BIOMED INC.*

    “George Robinson”
    Chief Executive Officer

    For further information, please contact:
    Mathieu McDonald, Corporate Communications: 604-484-1230

    Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

    Cautionary Note Regarding Forward-Looking Statements

    All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, including statements with respect to the fulfillment of cannabis orders and payment therefore pursuant to the supply agreement with Maricann, the first shipment of cannabis flower in March 2019 and its estimated 2019 cannabis production. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited to those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com.  Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements.  The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law. Reported by GlobeNewswire 32 minutes ago.

    0 0

    Italy's biggest builder Salini Impregilo and shipbuilder Fincantieri have won the contract to rebuild a bridge that collapsed in August, killing 43 people, in the port city of Genoa. Reported by Reuters 2 minutes ago.

    0 0

    After months of refusals to back down, the government said it would sharply reduce its debt to avoid financial penalties from the E.U. Reported by NYTimes.com 6 hours ago.

    0 0

    The government of Italy has reached a deal with the European Commission over the Rome's budget deficit, ending a stand-off that had upset bond markets and threatened to re-open the wider eurzone crisis. Reported by Independent 6 hours ago.

    0 0

    Italian Prime Minister Giuseppe Conte heralded on Wednesday a budget deal with the European Commission, saying the long-awaited accord allowed his government to honor its main commitments and boost the economy. Reported by Reuters 6 hours ago.

    0 0

    The European Commission has reached a deal with Italy over the country's 2019 budget that avoids immediate EU disciplinary steps against Rome, Commission Vice President Valdis Dombrovskis said on Wednesday, sending Italian bond yields sharply lower. Reported by Reuters 6 hours ago.

    0 0

    Italy budget deal struck with Europe after months-long row The agreement follows a high-profile diplomatic row that has lasted for months. Reported by BBC News 5 hours ago.

    0 0

    TORONTO, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”), a global, vertically integrated cultivator and processor of cannabis, today announced that its Board of Directors has initiated a process to explore a broad range of strategic alternatives, including, but not limited to assessing the potential spin-out and/or European listing of its international assets (the “International Assets”) in an effort to unlock the value of the Company’s vast international asset portfolio (a “Spinout Transaction”), as well as its underlying domestic Canadian assets. Any Spinout Transaction of the International Assets could include the Company’s European, Latin American, and Asia-Pacific operations.The Company strongly believes in its current strategy; however, it does not believe its current share price accurately reflects the global portfolio Wayland has, and continues to create.

    “We have demonstrated our capability in predicting future markets and working systematically to put supply chain in place, with some of the lowest transaction costs for international acquisitions in addition to organic growth and partnerships.  Our exponential growth model has tremendous potential, as it is built on the solid foundation we have laid from five years of organizational learning as a licensed producer in Canada. This has allowed us to become one of five companies with EU-GMP certification on top of having all the requisite cultivation and processing licenses in Canada. It is time for us to capitalize on the largest future cannabis market in the world and focus our efforts in the wellness and medical markets to accomplish our vision of enhancing life through cannabis,” stated Ben Ward, CEO of Wayland.

    Canaccord Genuity Corp. has been retained to serve as the Company’s financial advisor related to the strategic review process.

    There can be no assurance the strategic review will result in the completion of any transaction or any other alternative. The Company has not set a timetable for completion of the review process, and it does not intend to comment further unless a specific transaction or alternative is approved by the Board of Directors, the review process is concluded, or it is otherwise determined that other disclosure is appropriate.

    Paul Pathak, Chairman of the Board commented, “Our Board is committed to maximizing value for our shareholders. Our management team has done a terrific job of building a state of the art cultivation facility in Langton and securing significant distribution agreements with several of the Provinces, while at the same time assembling an impressive portfolio of international assets. Our end goal, however, is to translate that into value for our shareholders and we are confident that the results of our strategic review and potential spin-out of our international assets will be important steps to accomplish that.”

    *European Assets*

    Germany
    Wayland has several active initiatives in Germany that give the Company a distinct advantage in the German and European markets. The Company is the only organization in the world that has a facility ready for domestic cannabis cultivation. Located in Ebersbach, just outside of Dresden, the proposed facility gives Wayland 820,000 square feet of clean-room cultivation, processing, and extraction capabilities. It is currently being utilized to process industrial hemp from the Company’s adjacent 164-hectare hemp operation where the Company recently completed their first harvest yielding over 120,000 kg of dry hemp flowers. Once processed, the CBD distillate will be used for the Company’s recently launched nutraceutical business, MariPlant GmbH. Finally, the Company expects to receive their second EU-GMP certification for the Ebersbach facility in a matter of weeks, further strengthening Wayland’s medical production and distribution capabilities.

    Switzerland
    Wayland’s second European cultivation site is located in Regensdorf, Switzerland, a suburb of Zurich. The 60,000 square foot facility’s current production profile is approximately 2,000 kg of CBD flower per year. Wayland plans to upgrade this facility to bring it in line with the Company’s production standards from existing GACP standards and increase capacity to 14,000 kg per year with the goal of developing their own CBD products for sale throughout Switzerland and the rest of the European Union. Wayland will locate its Active Pharmaceutical Ingredients (API) manufacturing site for its global operations in Switzerland, taking advantage of existing phyto pharmaceutical talent in country.

    Italy
    Wayland has a definitive joint venture agreement with CBD Italian Factory S.S., a company of Group San Martino for the production of high quality cannabis products in Italy. The Company expects that the joint venture will marry the best of both entities with world-leading technology by Rockwell Automation paired with existing infrastructure in Piedmont, Italy, which includes agricultural expertise and biogas electricity. This will allow the sustainable production of quality CBD and THC products from a naturally derived fuel source. CBD Italian Factory S.S. and San Martino Group will bring mass-scale agricultural skills to the joint venture with a focus on local sustainable practices and expertise in Biomass Energy production. The Company holds 50.1 % of the joint venture while 49.9% is held by CBD Italian Factory, with Massimiliano Umberto Signorini assuming the role of CEO for the new company.

    Malta
    In July of 2018, Wayland’s application to Malta Enterprise to set up a business in Malta to manufacture finished dose medical cannabis was approved. Malta will offer the Company a unique advantage as Wayland will have the ability to import, extract, manufacture finished dose products, and distribute cannabis for medical purposes within Malta and the entire European Union. Malta Enterprise allows the Company to develop a wide variety of pharmaceutical products and export them across the European Union, and as Malta is a member of the EU, certain VAT tax are inapplicable to Malta Enterprise.

    United Kingdom
    The Company has entered into an agreement to acquire a 51% stake in U.K. based Theros Pharma Ltd. (“Theros”), an early stage company that has successfully imported cannabis to the U.K. for patients with a prescription for medical cannabis. The company expects to be able to import cannabis to patients in the UK as early as March 2019.

    *Latin American and Asia Pacific Assets*

    Argentina
    Wayland has entered into an agreement to purchase 819 hectares of existing developed agriculture land in San Juan Province in Argentina, which is the ideal micro climate for cultivation. The properly has existing mass scale irrigation, using runoff from the Andes Mountains, and produces 1,000,000 kg of wine juice, and 400,000 kg of olives per year.  Existing on site agronomists and farmers will take their knowledge of horticulture and apply it to Wayland’s existing world class system of cannabis cultivation. Outdoor cultivation will take place in existing alfalfa fields, to supply Wayland with low cost inputs.  Initial extraction will take place in Argentina.

    Colombia
    The Company has entered into an agreement to acquire 100% of the outstanding shares of Colma Pharmaceutical SAS (“Colma”), a licensed producer of THC cannabis in Colombia, holding four licenses for cultivation and processing on a leased premise in Ibaque, Colombia. Wayland plans to cultivate THC cannabis outdoor and year-round with an infrastructure investment including 415,000 square feet of processing and clone and vegetation greenhouse facilities to support outdoor cannabis flower production of 125 hectares.

    Australia
    Wayland has entered into an agreement to acquire 50.1% of Tropicann Pty Ltd. (“Tropicann”), a privately owned Australian company located in Darwin, Northern Territory. It plans to build an outdoor grow facility to take advantage of the ideal cannabis cultivation climate with minimal environmental impact. The Company believes it can leverage a major port in Darwin that will provide access to major APAC markets.

    *Canadian Assets*

    Canadian Operations
    The Company’s flagship facility is located in Langton, Ontario with cultivation, extraction, formulation, and distribution capabilities. The facility is a purpose-built cannabis production facility with an emphasis on automation and energy efficiencies. The Company partnered with Rockwell Automation to develop a fully automated system including the development of AI Data Grow, the Company’s artificially intelligent master grower. This allows Wayland to drastically reduce its cultivation labour needs by approximately 90% of the industry average while also mitigating risks associated with infecting crops. The facility will be completed in two phases, the first of which is approximately 225,000 square feet in size with 90,000 square feet of production and office space and approximately 135,000 square feet of grow space which will yield the Company approximately 65,000 kg of dried cannabis flower per year. Phase two will bring an additional 719,000 square feet of grow space online taking production capacity much greater than 100,000 kg per year.

    Wayland’s Langton campus has been certified by the European Medicines Agency after receiving the certification of EU-Good Manufacturing Practices (“EU-GMP”). EU-GMP certification allowed Wayland to sign the largest ever medical cannabis export deal with Cannamedical of Germany, agreeing to provide the medical cannabis distributor with a minimum of 9,000 kg of product over a three-year period. Wayland is one of only five cannabis companies in the world to receive the EU-GMP designation which is another advantage the Company believes it has in the global medical cannabis arena as demonstrated by this large purchase order.

    Provincial Agreements

    · *Manitoba*: Supply agreement with the Manitoba Liquor & Lotteries Corporation (“MBLL”) to make available for purchase by MBLL at least 550kg of various cannabis products during the first twelve months of the agreement.
    · *Alberta*: Supply Agreement with the Alberta Gaming, Liquor & Cannabis Commission (“AGLC”) to allocate up to 3,375kg of cannabis product for the Alberta market within the first six months.
    · *British Columbia*: Through a memorandum of understanding (“MOU”), Wayland is a preferred licensed producer to the BC Liquor Distribution Branch (“BCLDB”) to initially supply approximately 3,622kg of non-medical cannabis to BCLDB over the first 12 months following legalization.
    · *Ontario*: Selected by The Ontario Cannabis Store (“OCS”) to supply a variety of safe, high quality cannabis products through its online store since launching October 17, 2018.

    Brand Portfolio
    The Company has taken a purposeful and consumer-centric approach to each of its brands/offerings, each validated and optimized with local consumer research. Strains within each portfolio will match brand positioning and satisfy target consumer needs and benefits.

    · *Solara C*: Designed for the modern, active consumer who is looking to find solutions to help them live healthier/better without using stronger pharmaceutical alternatives. This brand will be CBD-only and create a wide range of products from beverages to topical creams with the expressed purpose of promoting a healthy, balanced lifestyle.

    · *Kiwi*: Designed for light users who are new to the category and looking to better understand Cannabis and its effects. The brand will exist to simplify and make the cannabis experience more welcoming and approachable to the masses.

    · *Northern Harvest*: Designed for light / medium users who enjoy Cannabis as part of their active and social lives. The brand will exist to promote a more natural and balanced approach to Cannabis with a focus on providing a fun and lighthearted experience.

    · *High Tide*: Designed for medium to heavy users who enjoy the cerebral effects of Cannabis. This brand will produce high quality, high THC cannabis with the expressed purpose of pushing the limits of the THC experience.

    · *Lost at Seed*: Designed for medium to heavy users who want only the best Cannabis money can buy. This brand will provide highly desirable and impossible to find strains only available on a limited assortment basis.

    · *Rare Dankness*: This partner brand will be for experienced Cannabis users who are knowledgeable about strains, potencies and profiles. It will offer a wide selection of premium award-winning strains that users won’t be able to find anywhere else.Maricann Group Inc., through its subsidiaries, is operating under the Wayland Group name. For further details see the press release dated September 24, 2018.

    *About Wayland Group**
    *

    Wayland is a vertically integrated cultivator and processor of cannabis. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a cannabis cultivation, extraction, formulation, and distribution business under federal licenses from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany, Regensdorf, Switzerland, Allesandria, Piedmont, Italy, Ibague, Colombia, London, UK, Australia, and Argentina. Wayland will continue to pursue new opportunities globally in its effort to enhance lives through cannabis.

    *Forward Looking Information*

    This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Such statements include statements regarding the Company's plans for its operations in all regions, proposed acquisitions, the Company’s continued global expansion, its effect on the Company’s global platform and the Spinout Transaction. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Such assumptions, risks, uncertainties and other factors include, but are not limited to, that the proposed transactions will be completed on the terms and timelines anticipated by the Company or at all, the effect that the proposed transactions, and Spinout Transaction if and when completed, will have on the Company’s global platform, that all necessary stock exchange, regulatory and other approvals will be received in connection with the proposed transactions and or the Spinout Transaction. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

    The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release

    For more information about Wayland, please visit our website at www.waylandgroup.com

    *Contact Information:*
    Investor Relations
    Graham Farrell
    VP, Communications
    Graham.Farrell@waylandgroup.com  
    647-643-7665

    *Media Inquiries: *media@waylandgroup.com 

    Corporate Headquarters (Canada)
    Wayland Group Corp. (Toronto)
    845 Harrington Court, Unit 3
    Burlington Ontario L7N 3P3
    Canada
    289-288-6274
    European Headquarters (Germany)
    Maricann GmbH
    Thierschstrasse 3, 80538 Munchen, Deutschland Reported by GlobeNewswire 6 hours ago.

    0 0

    BRUSSELS - The EU and Italy on Wednesday called a truce in their bitter row over Rome's disputed 2019 budget, as the populist government accepted to put off signature reforms. Reported by Bangkok Post 5 hours ago.

    0 0

    Backroads, the leader in adventure travel, announced most sought after destinations for 2019 - Europe, African Safaris, Argentina, Iceland and New Zealand top the list

    BERKELEY, Calif. (PRWEB) December 19, 2018

    Backroads, the leader in adventure travel, announced the most sought-after destinations for 2019. Europe topped the list, as Backroads guests are showing particular enthusiasm to explore classics like France, Italy, Portugal, Scotland and Spain, plus the newest Mediterranean hot-spot of Croatia. Interest in Active Africa Safaris is strong, inspiring new Backroads trips in Tanzania, Zambia and Botswana. Argentina, Iceland and New Zealand remain extremely popular with travelers of all ages.

    These hot-spots are some of the most sought-after 2019 destinations for early-booking.· Patagonia - Argentina 
    · Dolomites – Italy
    · North and South Islands – New Zealand
    · Lofoten Islands – Norway
    · Camino de Santiago - Spain and Portugal
    · Mallorca and Menorca Islands - Spain

    “It seems people want to get out in front of their New Year’s goals this year and plan early for 2019 adventures,” said Backroads President and Founder, Tom Hale. “Europe and Africa are hot destinations for active travel, particularly for families traveling together. With these trends in mind, we’re introducing some exciting new trips in 2019, including yoga and expanded options for families with older kids.”

    A pioneer in active and adventure travel, Backroads celebrates its 40th anniversary in 2019. Backroads was founded on the principles of creating extraordinary experiences for its guests, being the most guest-focused travel company on the planet and incorporating the highest quality possible into the philosophy and fabric of the company. 

    For a complete listing of Backroads Adventures tours, visit http://www.backroads.com  or call 1-800-462-2848. 

    About Backroads
    Backroads was founded in 1979 by Tom Hale and has been a leading innovator in active and adventure travel for 40 years. The company hosts thousands of guests each year, 75% of whom are repeat guests or referrals from past guests, in hundreds of locations across the globe. Backroads is a founding member of the Adventure Collection. For more information, please visit backroads.com or call 800-462-2848 daily, 6 a.m. to 6 p.m., Pacific time. Reported by PRWeb 5 hours ago.

    0 0

    Dublin, Dec. 19, 2018 (GLOBE NEWSWIRE) -- The "High Potent Medicine Conference" conference has been added to *ResearchAndMarkets.com's* offering.Drug product development for highly potent APIs (HPAPIs) can be challenging. Complications with the interface between operations in drug substance and drug product handling can result in increased program complexity and cost. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine.

    This is the 3rd Annual High Potent Medicines Conference to be held on 28th-29th May 2019 in Milan, Italy. The conference will focus on case studies related to development, rapid scaling, validation and commercial production of HPAPI drug substance, as well as integrated containment requirements for particle engineering and drug product. The 2-day event will share the latest industry trends, advancements and future growth in the highly potent medicines market where leading industry experts will discuss the strategies for both pharma and CMO's by presenting expert keynote presentations, live case studies and breathrough panel sessions.

    *Key Highlights*

    · Process validation considerations and scale-up in high potent compounds production
    · Strategies for effective management of high potent medicines supply chain
    · Overcoming regulatory challenges for ADC's
    · Validation of cleaning procedures to avoid cross contamination
    · Containment and safety of pharmaceutical toxic powders
    · Managing cleaning validation in biologics
    · Risk identification and mitigation for HPAPI's

    *Who Should Attend:*· Personnel from pharmaceutical manufacturing and Biopharmaceutical manufacturing
    · Chief executives, VP's, Directors, Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, Toxicologists, Fellows, Investigators working in the following departments;

    *Departments:*

    · Research & Development
    · Manufacturing/Operations/Production
    · Maintenance
    · Engineering
    · Quality
    · Regulatory
    · Risk Assessments
    · Laboratory Services/Analytical
    · New Technologies
    · Process Development/Technical transfer
    · Environmental, Health & Safety (HSE)
    · Occupational Toxicology
    · Industrial Hygiene
    · New Products
    · Product Quality
    · Innovations
    · Regulatory
    · Validation
    · Formulation Development
    · External Supply

    For more information about this conference visit https://www.researchandmarkets.com/research/nwwppb/two_day_high?w=12

    Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

    CONTACT:
    CONTACT: ResearchAndMarkets.com
    Laura Wood, Senior Press Manager
    press@researchandmarkets.com
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Drug Discovery Reported by GlobeNewswire 5 hours ago.

    0 0

    The euro notched up its biggest daily rise against the pound in more than a week as diminishing political worries in Italy and strong trade data contrasted with growing concerns about Britain's plans to avoid a "no-deal" Brexit. Reported by RTE.ie 4 hours ago.

    0 0

    Slovenian skier Ilka Stuhec overcame an error in the middle of her run to win a World Cup super-G on Wednesday and sweep the speed races on the Saslong course in Val Gardena, Italy. Reported by CBC.ca 4 hours ago.

    0 0

    ARCA, a leading provider of cash and check automation technology for financial and retail businesses, is pleased to announce the hiring of Stefano Parmegiani as Chief Manufacturing and Supply Chain Officer. Parmegiani has over 25 years of experience in Lean Production, Supply Chain Management, Industrial Engineering, Quality and Product Engineering.

    MEBANE, N.C. (PRWEB) December 19, 2018

    ARCA, a leading provider of cash and check automation technology for financial and retail businesses, is pleased to announce the hiring of Stefano Parmegiani as Chief Manufacturing and Supply Chain Officer. Parmegiani has over 25 years of experience in Lean Production, Supply Chain Management, Industrial Engineering, Quality and Product Engineering.

    Parmegiani comes to ARCA from Safilo SpA, the second largest global manufacturer of eyewear with 29 brands such as Polaroid, Dior, Fendi and Carrera. He was formerly the Director of Operations and Product Engineering for “Made in Italy” Acetate and Injected Eyewear division and was responsible for manufacturing at two industrial sites in Italy. His work experience also includes the Director of Operations at Franke, an international industrial manufacturer, and many leadership positions within Whirlpool Europe.

    "Stefano is a great addition to ARCA," says ARCA CEO Mort O'Sullivan. "Having a highly efficient manufacturing and supply chain is critical to delivering our products to customers. It's one of the areas that really impacts the success of any company in so many ways. Stefano has a great deal of experience in identifying opportunities to streamline the manufacturing process. We're very excited to put ARCA in the position to benefit from his knowledge and leadership."

    "One of the things I've really enjoyed during my career is leading diverse teams of people in finding new ways to drive results by working together more effectively," says Parmegiani. "ARCA is a global company, and while that presents logistical challenges, it also yields great reward when we find ways to leverage on our strengths and potential synergies. ARCA makes great products that provide great value for customers. I look forward to working with my new colleagues to even further improve our ability to develop and produce high quality products."

    Parmegiani holds a Master Engineering degree in Electronics from Politecnico di Milano. He has also studied finance and business administration at SDA Bocconi School of Management in Milan, and leadership development at the IMD Business School in Switzerland and The University of Chicago Booth School of Business. Parmegiani will oversee all manufacturing and supply chain operations from ARCA's R&D Center of Excellence located in Ivrea and Bollengo Italy. He and his wife and daughter live in the Milan/Varese area. Reported by PRWeb 4 hours ago.

    0 0

    Though heavy on the history, Rome and Venice are more than beautiful archives. They're complicated, living cities worth exploring. Reported by Seattle Times 4 hours ago.

    0 0

    The EU and Italy have today called a truce in their bitter row over Rome's disputed 2019 budget, as the populist government agreed to put off signature reforms. Reported by RTE.ie 4 hours ago.

    0 0

    Italy has promised to reduce its deficit targets for the next three years. Italian Prime Minister Giuseppe Conte said the long awaited agreement allowed his government to honor its main commitments and boost the economy. Reported by Deutsche Welle 4 hours ago.

    0 0

    A deal between Italy and the European Commission over its contested 2019 budget appeared to have been reached. Reported by euronews 4 hours ago.

    0 0

    The European Commission on Wednesday reached a deal with Italy over its 2019 budget, avoiding disciplinary steps against Rome, ending months of verbal sparring and buoying Italian bonds and shares. Reported by Reuters India 3 hours ago.

older | 1 | .... | 1079 | 1080 | (Page 1081) | 1082 | 1083 | .... | 1102 | newer